Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.
about
Metabolic Enzymes Enjoying New Partnerships as RNA-Binding ProteinsObese mice have increased morbidity and mortality compared to non-obese mice during infection with the 2009 pandemic H1N1 influenza virus.Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development.Glucocorticoid mediated regulation of inflammation in human monocytes is associated with depressive mood and obesity.Direct regulation of glucose and not insulin on hepatic hexose-6-phosphate dehydrogenase and 11β-hydroxysteroid dehydrogenase type 1Increased glycogen synthase kinase-3β and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposityTransgenic overexpression of hexose-6-phosphate dehydrogenase in adipose tissue causes local glucocorticoid amplification and lipolysis in male mice.Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia.Glucocorticoid hormones and energy homeostasis.Specific reduction of G6PT may contribute to downregulation of hepatic 11β-HSD1 in diabetic mice.Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes.Glucocorticoid signaling in the liver and adipose tissue of male and female fructose-fed rats.Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes.Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes.Interplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus.
P2860
Q26777647-08FB2D98-3471-472B-A7BC-C75878FB71ACQ30403762-FD973BAB-BBAD-4A58-9E4D-9507A72C0417Q36164584-881D0E11-A8CA-47ED-B051-B3FC42EB290EQ36688882-E8CD6B82-2AB7-496A-AD07-5E282DB958E6Q37089880-C9C9F385-2922-4EB1-ACE9-715BDD5F028DQ37146798-73AB28E1-7213-4F52-A7CC-2E2DED3320ECQ37629023-73ABCBF8-587D-494B-A32D-2B430F1203D0Q37640920-4D0215E6-0F61-4C7B-A9F0-BF8B086CF16BQ38267496-4CA8A97B-793E-415F-9339-B86AD9F4DCC1Q39220866-6353E8E1-3379-48CB-B4B4-C3DA2286AEF0Q42668655-A9ED97F4-93EF-4D36-8FF7-957BB2FC4A9AQ46035278-6D7275CB-323F-4624-9D1F-7D93BF58755EQ46125858-01B54D02-8473-409C-B5D8-E7B013667906Q46135112-2A730F2B-29E2-4A61-8398-66C194288C69Q48019755-0549B7A9-5149-444A-BAE9-8076EEC12117
P2860
Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Reduction of hepatic glucocort ...... nd insulin resistance in mice.
@ast
Reduction of hepatic glucocort ...... nd insulin resistance in mice.
@en
Reduction of hepatic glucocort ...... nd insulin resistance in mice.
@nl
type
label
Reduction of hepatic glucocort ...... nd insulin resistance in mice.
@ast
Reduction of hepatic glucocort ...... nd insulin resistance in mice.
@en
Reduction of hepatic glucocort ...... nd insulin resistance in mice.
@nl
prefLabel
Reduction of hepatic glucocort ...... nd insulin resistance in mice.
@ast
Reduction of hepatic glucocort ...... nd insulin resistance in mice.
@en
Reduction of hepatic glucocort ...... nd insulin resistance in mice.
@nl
P2093
P2860
P356
P1476
Reduction of hepatic glucocort ...... nd insulin resistance in mice.
@en
P2093
Hongwei Du
Kabirullah Lutfy
Theodore C Friedman
Xiuhai Ren
Yanjun Liu
Yuichi Nakagawa
P2860
P356
10.1677/JME-08-0004
P577
2008-06-04T00:00:00Z